Capital Flow Monitor · Sponsors · CIK 1881025
Ride Health, Inc.
228 Park Ave South, NEW YORK, NY, 10003 · (303) 501-9630
Other Technology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$16.4M
Sold
$15.5M
% sold
94.5%
Investors
21
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-12-17 | D/A ·current | 506(b) | $16.4M | $15.5M | 94.5% | 21 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Imran Cronk — Director, New York, NY
- Daniel Faath — Executive Officer / Director, New York, NY
-
Michael Reardon — Executive Officer, New York, NY
2 other raises
- Antares Unitholder Investment LLC $125.6M of —
- Aqua Membranes, Inc. $25.1M of $25.1M · 100.0%
-
Todd Pietri — Director, New York, NY
1 other raise
- Inception Point AI Inc $5.1M of $5.1M · 100.0%
-
Brian Model — Director, New York, NY
2 other raises
- EULERITY, INC. $4.5M of $5.0M · 90.0%
- Thunder GPU, Inc. $15.7M of $17.6M · 89.3%
- Samir Malik — Director, New York, NY
-
Andrew Schwab — Director, New York, NY
2 other raises
- S2N Health Inc. $3.0M of $3.0M · 100.0%
- TMRW Life Sciences, Inc. $38.4M of $38.4M · 100.0%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.